These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 36446904)
1. Epithelial and stromal co-evolution and complicity in pancreatic cancer. Hingorani SR Nat Rev Cancer; 2023 Feb; 23(2):57-77. PubMed ID: 36446904 [TBL] [Abstract][Full Text] [Related]
2. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression]. Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Provenzano PP; Hingorani SR Br J Cancer; 2013 Jan; 108(1):1-8. PubMed ID: 23299539 [TBL] [Abstract][Full Text] [Related]
4. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment. Sun H; Zhang B; Li H Technol Cancer Res Treat; 2020; 19():1533033820920969. PubMed ID: 32372692 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies. Kuznetsova A; Popova O; Panchenkov D; Dyuzheva T; Ivanov A Clin Exp Med; 2023 Jul; 23(3):619-643. PubMed ID: 36085429 [TBL] [Abstract][Full Text] [Related]
6. Functional significance of macrophages in pancreatic cancer biology. Hu H; Jiao F; Han T; Wang LW Tumour Biol; 2015 Dec; 36(12):9119-26. PubMed ID: 26411672 [TBL] [Abstract][Full Text] [Related]
7. Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked. Evan GI; Hah N; Littlewood TD; Sodir NM; Campos T; Downes M; Evans RM Clin Cancer Res; 2017 Apr; 23(7):1647-1655. PubMed ID: 28373363 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. Ijichi H; Chytil A; Gorska AE; Aakre ME; Bierie B; Tada M; Mohri D; Miyabayashi K; Asaoka Y; Maeda S; Ikenoue T; Tateishi K; Wright CV; Koike K; Omata M; Moses HL J Clin Invest; 2011 Oct; 121(10):4106-17. PubMed ID: 21926469 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202 [TBL] [Abstract][Full Text] [Related]
12. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice. Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028 [TBL] [Abstract][Full Text] [Related]
13. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mahadevan D; Von Hoff DD Mol Cancer Ther; 2007 Apr; 6(4):1186-97. PubMed ID: 17406031 [TBL] [Abstract][Full Text] [Related]
14. Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype. Ricci F; Kern SE; Hruban RH; Iacobuzio-Donahue CA Cancer Biol Ther; 2005 Mar; 4(3):302-7. PubMed ID: 15876873 [TBL] [Abstract][Full Text] [Related]
15. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Jiang H; Torphy RJ; Steiger K; Hongo H; Ritchie AJ; Kriegsmann M; Horst D; Umetsu SE; Joseph NM; McGregor K; Pishvaian MJ; Blais EM; Lu B; Li M; Hollingsworth M; Stashko C; Volmar K; Yeh JJ; Weaver VM; Wang ZJ; Tempero MA; Weichert W; Collisson EA J Clin Invest; 2020 Sep; 130(9):4704-4709. PubMed ID: 32749238 [TBL] [Abstract][Full Text] [Related]
17. Epithelial-Stromal Interactions in Pancreatic Cancer. Zhang Y; Crawford HC; Pasca di Magliano M Annu Rev Physiol; 2019 Feb; 81():211-233. PubMed ID: 30418798 [TBL] [Abstract][Full Text] [Related]
18. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Christenson ES; Jaffee E; Azad NS Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117 [TBL] [Abstract][Full Text] [Related]
19. Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Neesse A; Bauer CA; Öhlund D; Lauth M; Buchholz M; Michl P; Tuveson DA; Gress TM Gut; 2019 Jan; 68(1):159-171. PubMed ID: 30177543 [TBL] [Abstract][Full Text] [Related]
20. Understanding the stroma of pancreatic cancer: co-evolution of the microenvironment with epithelial carcinogenesis. Erkan M J Pathol; 2013 Sep; 231(1):4-7. PubMed ID: 23716361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]